Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Fish and Richardson
AstraZeneca
Cantor Fitzgerald
Cerilliant
Julphar
Mallinckrodt
Dow
Baxter

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,894,064

« Back to Dashboard

Which drugs does patent 6,894,064 protect, and when does it expire?

Patent 6,894,064 protects EVISTA and is included in one NDA.

This patent has forty-three patent family members in thirty-three countries.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.
Summary for Patent: 6,894,064
Title: Benzothiophenes, formulations containing same, and methods
Abstract:This invention provides compounds of formula I ##STR1## and pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.
Inventor(s): Arbuthnot; Gordon Nelson (Indianapolis, IN), Dalder; Brian Weston (West Lafayette, IN), Hartauer; Kerry John (Indianapolis, IN), Luke; Wayne Douglas (West Lafayette, IN), Stratford, Jr.; Robert Eugene (Carmel, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:10/811,260
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 6,894,064

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815-001 Dec 9, 1997 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,894,064

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,458,811 Benzothiophenes formulations containing same and methods ➤ Subscribe
6,797,719 Benzothiophenes, formulations containing same, and methods ➤ Subscribe
8,030,330 Benzothiophenes, formulations containing same, and methods ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,894,064

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 006387 ➤ Subscribe
Austria 464897 ➤ Subscribe
Australia 2215497 ➤ Subscribe
Australia 723797 ➤ Subscribe
Brazil 9708248 ➤ Subscribe
Canada 2250191 ➤ Subscribe
China 1162153 ➤ Subscribe
China 1213967 ➤ Subscribe
Colombia 4780022 ➤ Subscribe
Czech Republic 300341 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Farmers Insurance
Dow
US Department of Justice
Cantor Fitzgerald
Deloitte
Fish and Richardson
Colorcon
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot